Longboard Pharmaceuticals Inc [NASDAQ: LBPH] stock went on an upward path that rose over 51.65% on Monday, amounting to a one-week price increase of more than 76.88%.
Over the last 12 months, LBPH stock rose by 1049.90%. The one-year Longboard Pharmaceuticals Inc stock forecast points to a potential upside of 13.62. The average equity rating for LBPH stock is currently 2.43, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $2.29 billion, with 38.90 million shares outstanding and 33.57 million shares in the current float. Compared to the average trading volume of 664.20K shares, LBPH stock reached a trading volume of 43081054 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Longboard Pharmaceuticals Inc [LBPH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for LBPH shares is $68.29 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on LBPH stock is a recommendation set at 2.43. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Truist have made an estimate for Longboard Pharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 10, 2024. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price from $60 to $90. The new note on the price target was released on July 01, 2024, representing the official price target for Longboard Pharmaceuticals Inc stock. Previously, the target price had yet another raise to $36, while Robert W. Baird analysts kept a Outperform rating on LBPH stock.
The Average True Range (ATR) for Longboard Pharmaceuticals Inc is set at 4.31 The Price to Book ratio for the last quarter was 7.79, with the Price to Cash per share for the same quarter was set at 7.84.
LBPH Stock Performance Analysis:
Longboard Pharmaceuticals Inc [LBPH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 76.88. With this latest performance, LBPH shares gained by 71.88% in over the last four-week period, additionally plugging by 223.23% over the last 6 months – not to mention a rise of 1049.90% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for LBPH stock in for the last two-week period is set at 82.01, with the RSI for the last a single of trading hit 88.10, and the three-weeks RSI is set at 77.05 for Longboard Pharmaceuticals Inc [LBPH]. The present Moving Average for the last 50 days of trading for this stock 34.86, while it was recorded at 39.85 for the last single week of trading, and 25.83 for the last 200 days.
Insight into Longboard Pharmaceuticals Inc Fundamentals:
Longboard Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 20.95 and a Current Ratio set at 20.95.
LBPH Stock EPS
With the latest financial reports released by the company, Longboard Pharmaceuticals Inc posted -0.55/share EPS, while the average EPS was predicted by analysts to be reported at -0.7/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.15. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for LBPH.
Longboard Pharmaceuticals Inc [LBPH] Institutonal Ownership Details
There are presently around $119.32%, or 120.90%% of LBPH stock, in the hands of institutional investors. The top three institutional holders of LBPH stocks are: FMR LLC with ownership of 4.42 million shares, which is approximately 11.3559%. RA CAPITAL MANAGEMENT, L.P., holding 3.29 million shares of the stock with an approximate value of $$88.9 million in LBPH stocks shares; and RA CAPITAL MANAGEMENT, L.P., currently with $$79.48 million in LBPH stock with ownership which is approximately 7.5629%.
